Searching News Database: genomic
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 20 Feb 2026
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
HSMN NewsFeed - 19 May 2025
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
HSMN NewsFeed - 6 Mar 2025
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
HSMN NewsFeed - 26 Aug 2024
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
HSMN NewsFeed - 22 Jul 2024
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
HSMN NewsFeed - 20 May 2024
Chroma Medicine Announces Appointment of Jenny Marlowe, Ph.D., as Chief Development Officer
Chroma Medicine Announces Appointment of Jenny Marlowe, Ph.D., as Chief Development Officer
HSMN NewsFeed - 29 Mar 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
HSMN NewsFeed - 16 May 2023
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
HSMN NewsFeed - 14 Oct 2022
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
HSMN NewsFeed - 13 Jul 2022
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
HSMN NewsFeed - 7 Jul 2022
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
HSMN NewsFeed - 3 Jun 2022
Caris Life Sciences Introduces the Caris Assure(TM) Liquid Biopsy Assay at ASCO 2022
Caris Life Sciences Introduces the Caris Assure(TM) Liquid Biopsy Assay at ASCO 2022
HSMN NewsFeed - 17 May 2022
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
HSMN NewsFeed - 1 Feb 2022
Biofidelity Raises $23M in Series A+ Financing led by Octopus Ventures to Launch ASPYRE Technology
Biofidelity Raises $23M in Series A+ Financing led by Octopus Ventures to Launch ASPYRE Technology
HSMN NewsFeed - 9 Nov 2021
Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer
Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer
HSMN NewsFeed - 12 Oct 2021
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
HSMN NewsFeed - 21 Sep 2021
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
HSMN NewsFeed - 8 Sep 2021
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
HSMN NewsFeed - 2 Sep 2021
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
HSMN NewsFeed - 13 Jul 2021
Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
HSMN NewsFeed - 13 Apr 2021
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
HSMN NewsFeed - 10 Mar 2021
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
HSMN NewsFeed - 6 Nov 2020
Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors
Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors
HSMN NewsFeed - 19 Oct 2020
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
HSMN NewsFeed - 26 Aug 2020
MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics
MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics
HSMN NewsFeed - 22 Jul 2020
Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2
Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2
HSMN NewsFeed - 20 Jul 2020
Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test
Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test
HSMN NewsFeed - 22 Jun 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
HSMN NewsFeed - 1 Jun 2020
PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals
PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals
HSMN NewsFeed - 19 May 2020
ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions
ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions
HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
HSMN NewsFeed - 3 Mar 2020
DxTerity Receives CE Mark for DxCollect(R) Fingerstick Blood RNA Stabilization Device
DxTerity Receives CE Mark for DxCollect(R) Fingerstick Blood RNA Stabilization Device
HSMN NewsFeed - 24 Feb 2020
Karius Secures $165 Million In Series B Funding Led By SoftBank Vision Fund 2
Karius Secures $165 Million In Series B Funding Led By SoftBank Vision Fund 2
HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
HSMN NewsFeed - 13 Feb 2020
Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
HSMN NewsFeed - 11 Feb 2020
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
HSMN NewsFeed - 29 Jan 2020
Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application
Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application
HSMN NewsFeed - 9 Jan 2020
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
HSMN NewsFeed - 9 Jan 2020
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
HSMN NewsFeed - 7 Jan 2020
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 30 Dec 2019
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
HSMN NewsFeed - 17 Oct 2019
World-Renowned Cancer Leader Brian Leyland-Jones Named Chairman of NED Biosystems' Scientific Advisory Board
World-Renowned Cancer Leader Brian Leyland-Jones Named Chairman of NED Biosystems' Scientific Advisory Board
HSMN NewsFeed - 15 Oct 2019
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
HSMN NewsFeed - 11 Oct 2019
Transplant Genomics, Inc. Confirms TruGraf(R) Will Receive Medicare Coverage Effective November 25, 2019
Transplant Genomics, Inc. Confirms TruGraf(R) Will Receive Medicare Coverage Effective November 25, 2019
HSMN NewsFeed - 22 Apr 2019
Epic Sciences Appoints Richard J. Wenstrup, M.D. as Chief Medical Officer
Epic Sciences Appoints Richard J. Wenstrup, M.D. as Chief Medical Officer
HSMN NewsFeed - 30 Jan 2019
ArcherDX Acquires Baby Genes, a Genetics-Based Personalized Medicine Company
ArcherDX Acquires Baby Genes, a Genetics-Based Personalized Medicine Company
HSMN NewsFeed - 4 Jan 2019
SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine
SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine
HSMN NewsFeed - 5 Nov 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Biocept Announces New Executive Hires to its Sales and Marketing Organization
HSMN NewsFeed - 16 Oct 2018
Precision For Medicine Acquires Liquid Biopsy And Tissue Profiling Pioneer ApoCell
Precision For Medicine Acquires Liquid Biopsy And Tissue Profiling Pioneer ApoCell
HSMN NewsFeed - 18 Sep 2018
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
HSMN NewsFeed - 5 Sep 2018
ArcherDX, Inc. Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
ArcherDX, Inc. Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
HSMN NewsFeed - 28 Aug 2018
ArcherDX, Inc. Appoints Marvin H. Caruthers, Ph.D., to its Board of Directors
ArcherDX, Inc. Appoints Marvin H. Caruthers, Ph.D., to its Board of Directors
HSMN NewsFeed - 21 Aug 2018
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
HSMN NewsFeed - 4 Jun 2018
AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
HSMN NewsFeed - 11 Apr 2018
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
HSMN NewsFeed - 21 Mar 2018
Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures
Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures
HSMN NewsFeed - 13 Mar 2018
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
HSMN NewsFeed - 7 Mar 2018
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
HSMN NewsFeed - 22 Feb 2018
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
HSMN NewsFeed - 15 Jan 2018
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
HSMN NewsFeed - 3 Jan 2018
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
HSMN NewsFeed - 3 Jan 2018
Denovo Biopharma Opens New R&D Center, Names Chief Medical Officer and Chief Financial Officer
Denovo Biopharma Opens New R&D Center, Names Chief Medical Officer and Chief Financial Officer
HSMN NewsFeed - 19 Dec 2017
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
HSMN NewsFeed - 19 Dec 2017
Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer
Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer
HSMN NewsFeed - 7 Dec 2017
Dr. Aradhana Ghosh Joins Precision Medicine Leader Syapse As Vice President of Oncology
Dr. Aradhana Ghosh Joins Precision Medicine Leader Syapse As Vice President of Oncology
HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
HSMN NewsFeed - 30 Nov 2017
Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
HSMN NewsFeed - 16 Nov 2017
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines
HSMN NewsFeed - 20 Sep 2017
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
HSMN NewsFeed - 11 Sep 2017
Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof
Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof
HSMN NewsFeed - 28 Aug 2017
MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina
MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina
HSMN NewsFeed - 10 Aug 2017
Aevi Genomic Medicine Announces Agreement for $28 Million Private Placement
Aevi Genomic Medicine Announces Agreement for $28 Million Private Placement
HSMN NewsFeed - 29 Jun 2017
Agena Bioscience Launches CE-IVD System For Hospitals And Diagnostic Laboratories In Europe
Agena Bioscience Launches CE-IVD System For Hospitals And Diagnostic Laboratories In Europe
HSMN NewsFeed - 20 Jun 2017
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
HSMN NewsFeed - 23 May 2017
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
HSMN NewsFeed - 17 May 2017
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
HSMN NewsFeed - 9 May 2017
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
HSMN NewsFeed - 4 Apr 2017
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
HSMN NewsFeed - 22 Feb 2017
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
HSMN NewsFeed - 20 Feb 2017
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
HSMN NewsFeed - 15 Feb 2017
Cepheid Announces FDA Clearance Of Xpert(R) Xpress Flu And Xpert Xpress Flu/RSV
Cepheid Announces FDA Clearance Of Xpert(R) Xpress Flu And Xpert Xpress Flu/RSV
HSMN NewsFeed - 7 Feb 2017
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
HSMN NewsFeed - 20 Jan 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
HSMN NewsFeed - 17 Jan 2017
Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development
Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development
HSMN NewsFeed - 16 Jan 2017
Bio-Rad to Acquire RainDance Technologies and Droplet Intellectual Property
Bio-Rad to Acquire RainDance Technologies and Droplet Intellectual Property
HSMN NewsFeed - 8 Nov 2016
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
HSMN NewsFeed - 22 Aug 2016
Singlera Genomics Raises $20 Million In Series A Financing Led by Lilly Asia Ventures
Singlera Genomics Raises $20 Million In Series A Financing Led by Lilly Asia Ventures
HSMN NewsFeed - 26 Jul 2016
Inivata Adds to Board of Directors With Appointment of Peter Wrighton-Smith
Inivata Adds to Board of Directors With Appointment of Peter Wrighton-Smith
HSMN NewsFeed - 20 Jul 2016
Viracor-IBT Laboratories, Inc.'s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA
Viracor-IBT Laboratories, Inc.'s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA
HSMN NewsFeed - 25 May 2016
Inivata Boosts Executive Team With Appointment of Clive Morris as Chief Medical Officer
Inivata Boosts Executive Team With Appointment of Clive Morris as Chief Medical Officer
HSMN NewsFeed - 19 May 2016
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
HSMN NewsFeed - 16 May 2016
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
HSMN NewsFeed - 9 May 2016
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
HSMN NewsFeed - 8 Mar 2016
Arbutus Appoints Dr. Elizabeth Howard Executive Vice President and General Counsel
Arbutus Appoints Dr. Elizabeth Howard Executive Vice President and General Counsel
HSMN NewsFeed - 8 Mar 2016
Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls
Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls
HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
HSMN NewsFeed - 3 Mar 2016
Lumira Capital Announces Expansion of Investment Team with Appointment of Three Venture Partners
Lumira Capital Announces Expansion of Investment Team with Appointment of Three Venture Partners
HSMN NewsFeed - 17 Feb 2016
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer
HSMN NewsFeed - 12 Feb 2016
MedGenome Announces $10 Million Commitment to GenomeAsia 100K to Sequence 100,000 Genomes in South Asia
MedGenome Announces $10 Million Commitment to GenomeAsia 100K to Sequence 100,000 Genomes in South Asia
HSMN NewsFeed - 4 Feb 2016
GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy
GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy
HSMN NewsFeed - 12 Jan 2016
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
HSMN NewsFeed - 5 Jan 2016
Editas Medicine Expands Leadership Team with Key Organizational Appointments
Editas Medicine Expands Leadership Team with Key Organizational Appointments
HSMN NewsFeed - 10 Dec 2015
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
HSMN NewsFeed - 12 Nov 2015
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)
HSMN NewsFeed - 3 Nov 2015
Castle Biosciences Announces the Appointment of Federico Monzon, M.D., FCAP as Chief Medical Officer
Castle Biosciences Announces the Appointment of Federico Monzon, M.D., FCAP as Chief Medical Officer
HSMN NewsFeed - 28 Oct 2015
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates
HSMN NewsFeed - 27 Oct 2015
Transgenomic Launches New Genetic Testing Service for Diagnosis of Charcot-Marie-Tooth Syndrome
Transgenomic Launches New Genetic Testing Service for Diagnosis of Charcot-Marie-Tooth Syndrome
HSMN NewsFeed - 15 Oct 2015
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
HSMN NewsFeed - 7 Oct 2015
Luminex Corporation Receives FDA Clearance for ARIES(R) System and ARIES(R) HSV 1&2 Assay
Luminex Corporation Receives FDA Clearance for ARIES(R) System and ARIES(R) HSV 1&2 Assay
HSMN NewsFeed - 30 Sep 2015
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
HSMN NewsFeed - 21 Sep 2015
Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
HSMN NewsFeed - 10 Sep 2015
Metamark Genetics Appoints Kenneth E. Weg as President and Chief Executive Officer
Metamark Genetics Appoints Kenneth E. Weg as President and Chief Executive Officer
HSMN NewsFeed - 14 Jul 2015
Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy
Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy
HSMN NewsFeed - 18 Jun 2015
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
HSMN NewsFeed - 18 Feb 2015
Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy
Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy
HSMN NewsFeed - 3 Sep 2014
Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board
Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board
HSMN NewsFeed - 21 Aug 2014
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 30 Jul 2014
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
HSMN NewsFeed - 7 Jul 2014
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
HSMN NewsFeed - 14 May 2014
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer
HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
HSMN NewsFeed - 8 Apr 2014
Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development
Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development
HSMN NewsFeed - 18 Mar 2014
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
HSMN NewsFeed - 13 Mar 2014
CombiMatrix Announces Partnership With American Pathology Partners to Provide Products of Conception Testing
CombiMatrix Announces Partnership With American Pathology Partners to Provide Products of Conception Testing
HSMN NewsFeed - 5 Mar 2014
Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group(TM)
Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group(TM)
HSMN NewsFeed - 18 Feb 2014
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
HSMN NewsFeed - 29 Jan 2014
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
HSMN NewsFeed - 19 Dec 2013
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
HSMN NewsFeed - 9 Dec 2013
LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform
LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform
HSMN NewsFeed - 5 Dec 2013
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
HSMN NewsFeed - 19 Nov 2013
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development
HSMN NewsFeed - 8 Oct 2013
Molecular Templates Announces $8.5M Series C Financing and $10.6M Grant Funding
Molecular Templates Announces $8.5M Series C Financing and $10.6M Grant Funding
HSMN NewsFeed - 1 Oct 2013
First urine-based cancer mutation monitoring test available from Trovagene
First urine-based cancer mutation monitoring test available from Trovagene
HSMN NewsFeed - 10 Sep 2013
Metamark Announces Positive Results of ProMark(TM) Prostate Cancer Clinical Validation Study
Metamark Announces Positive Results of ProMark(TM) Prostate Cancer Clinical Validation Study
HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
HSMN NewsFeed - 24 Jul 2013
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
HSMN NewsFeed - 22 May 2013
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
HSMN NewsFeed - 12 Apr 2013
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
HSMN NewsFeed - 5 Mar 2013
Myriad's Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study
Myriad's Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study
HSMN NewsFeed - 12 Feb 2013
Aviir Secures Second $10 Million Financing Tranche; Attracts New Investor Group
Aviir Secures Second $10 Million Financing Tranche; Attracts New Investor Group
HSMN NewsFeed - 4 Feb 2013
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
HSMN NewsFeed - 10 Jan 2013
Pathway Genomics Names Todd G. Johnson as Vice President of Sales and Marketing
Pathway Genomics Names Todd G. Johnson as Vice President of Sales and Marketing
HSMN NewsFeed - 20 Dec 2012
Venaxis Board Appoints Senior Diagnostics Executive to Board of Directors
Venaxis Board Appoints Senior Diagnostics Executive to Board of Directors
HSMN NewsFeed - 11 Oct 2012
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
HSMN NewsFeed - 2 Oct 2012
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
HSMN NewsFeed - 25 Sep 2012
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
HSMN NewsFeed - 20 Sep 2012
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
HSMN NewsFeed - 13 Sep 2012
Transgenomic Announces Appointment of Mark P. Colonnese as Chief Financial Officer
Transgenomic Announces Appointment of Mark P. Colonnese as Chief Financial Officer
HSMN NewsFeed - 25 Jul 2012
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development
Additional items found! 500
Members Archive contains
500 additional stories matching:
genomic
(Password required)
genomic
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!